READ HERE for an update on Aetna.

Sarah Rutherford, M.D.

Hematology/Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

My first priority is the patient sitting in front of me. I have a longstanding interest in cancer care and have been specifically focused on lymphoma since my father was diagnosed with Hodgkin lymphoma when I was a medical student. At Weill Cornell, our experienced team of lymphoma specialists works together to determine the most appropriate therapy for each individual patient. Our group has played a key role in the development of many new therapies approved for lymphoma in recent years. As a result, our patients have early access to new and promising lymphoma treatments. We are fortunate to have a strong team of physician assistants, nurses, medical technicians, pharmacists, and administrative staff. This environment enables me to provide my patients with the best possible level of care.

Biographical Info

Dr. Sarah Rutherford is an Assistant Professor of Medicine in the Division of Hematology/Oncology at Weill Cornell Medicine. She is a graduate of the University of Virginia School of Medicine. She completed Internship and Residency in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia and Fellowship in Hematology/Oncology at New York-Presbyterian Hospital/Weill Cornell Medical College.  

Dr. Rutherford has clinical expertise in lymphoma. Her research focuses on improving outcomes in patients with aggressive lymphomas. She has a particular interest in helping patients to have an accurate understanding of their diagnosis. She has received honors from Weill Cornell Medical College and the American Society of Hematology, and support from the New York State Empire Clinical Research Investigator Program for her research in diffuse large B-cell lymphoma. She has experience in caring for patients with a variety of lymphomas and hematologic disorders including Hodgkin lymphoma, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and marginal zone lymphoma.  

Honors and Awards

National Institutes of Health Loan Repayment Award, National Cancer Institute 2017

John P. Leonard, M.D./Gwirtzman Family Research Scholar in Lymphoma

2017

Lymphoma Research Foundation Research Mentoring Program 2017

American Society of Hematology Clinical Research Training Institute 2015

American Society of Hematology Abstract Achievement Award 2014

Weill Cornell Medical College Department of Medicine Fellow in Research

Award Finalist 2014

New York State Empire Clinical Research Investigator Program 2014-2016

Gold Humanism Honor Society 2009

Phi Beta Kappa Society 2003

 

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
Hematologic Malignancy
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Benign Hematologic Disorders
Immunotherapy
Languages
English
Education 
  • M.D.
    University of Virginia School of Medicine
    2009
  • B.A.
    University of Virginia
    2003
Appointments 
  • Assistant Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Assistant Attending Physician
    NewYork-Presbyterian Hospital
Videos

Sarah Rutherford, M.D.

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Consultant: 
ADC Therapeutics
BMS
Genmab, Inc.
Kite Pharmaceuticals
Seagen Inc.
Professional Services: 
Karyopharm Therapeutics, Inc.